News
--(BUSINESS WIRE)--Aulos™ Bioscience, an immuno-oncology company working to revolutionize cancer care through development of its lead immune-activating antibody therapeutic, today presented ...
LARKSPUR, Calif.--(BUSINESS WIRE)--Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics ...
LARKSPUR, Calif., April 14, 2025--(BUSINESS WIRE)--Aulos™ Bioscience, an immuno-oncology company working to revolutionize cancer care through development of immune-activating antibody ...
LARKSPUR, Calif., March 25, 2025--(BUSINESS WIRE)--Aulos™ Bioscience, an immuno-oncology company working to revolutionize cancer care through development of potentially best-in-class IL-2 ...
ATP and Biolojic Design have teamed up to create IL-2-focused cancer biotech Aulos Bioscience. The startup begins life with IL-2-binding monoclonal antibodies designed by Biolojic Design and a $40 ...
The 'aulos' in the Ure Museum is the best known example of a popular musical instrument from ancient Greece. Although it looks like a flute, our single pipe was actually half of a double aulos ...
Leo Redmond has been appointed chief financial officer for Larkspur-based Aulos Bioscience, a new biotechnology company focusing on cancer treatments. Redmonds, who will work from the company’s ...
Aulos Bioscience Presents New Phase 2 Data for AU-007 Demonstrating Continued Strong Anti-Tumor Activity in Advanced Cancers at AACR Annual Meeting Data show clear evidence of anti-tumor activity ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results